Phase Bioscience appoints Craig Rosen executive chairman
Published: Thu, Oct. 09, 2008 12:30AM
Modified Thu, Oct. 09, 2008 02:44AM
E-Mail
Print
tool name
closeMORRISVILLE -- Drug development company Phase Bioscience has named biotechnology industry heavy hitter Craig Rosen its executive chairman.
Rosen, 50, is former president and chief scientific officer of Human Genome Sciences and co-founder, chief scientific officer and executive chairman of CoGenesys, which Teva Biopharmaceuticals acquired for $400 million earlier this year.
Rosen, who got to know Phase Bio CEO Chris Prior when Human Genome Sciences acquired a company founded by Prior, said he is impressed by Phase Bio's technology and its drugs, which are in preclinical development.
More Business
"I'm more than a chairman, just going to board meetings," said Rosen. "I have an interest in this technology. I want to see it develop. Hopefully, I can use my contacts to bring these drugs along."
Founded in 2002, Phase Bio has 17 employees and has raised $8 million in venture capital to date. After hiring Prior in April, the company switched focus from providing services to biotech companies to developing drugs of its own.
All rights reserved. This copyrighted material may not be published, broadcast or redistributed in any manner.
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.
